Beta-amyloid fragment 25-35 causes mitochondrial dysfunction in primary cortical neurons

Neurobiol Dis. 2002 Aug;10(3):258-67. doi: 10.1006/nbdi.2002.0516.

Abstract

Beta-amyloid deposition and compromised energy metabolism both occur in vulnerable brain regions in Alzheimer's disease. It is not known whether beta-amyloid is the cause of impairment of energy metabolism, nor whether impaired energy metabolism is specific to neurons. Our results, using primary neuronal cultures, show that 24-h incubation with A beta(25-35) caused a generalized decrease in the specific activity of mitochondrial enzymes per milligram of cellular protein, induced mitochondrial swelling, and decreased total mitochondrial number. Incubation with A beta(25-35) decreased ATP concentration to 58% of control in neurons and 71% of control in astrocytes. Levels of reduced glutathione were also lowered by A beta(25-35) in both neurons (from 5.1 to 2.9 nmol/mg protein) and astrocytes (from 25.2 to 14.9 nmol/mg protein). We conclude that 24-h treatment with extracellular A beta(25-35) causes mitochondrial dysfunction in both astrocytes and neurons, the latter being more seriously affected. In astrocytes mitochondrial impairment was confined to complex I inhibition, whereas in neurons a generalized loss of mitochondria was seen.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Amyloid beta-Peptides / pharmacology*
  • Animals
  • Animals, Newborn
  • Astrocytes / drug effects
  • Astrocytes / enzymology
  • Astrocytes / pathology
  • Cells, Cultured
  • Cerebral Cortex / drug effects*
  • Cerebral Cortex / enzymology
  • Cerebral Cortex / pathology
  • Embryo, Mammalian
  • Mitochondria / drug effects*
  • Mitochondria / metabolism
  • Mitochondria / pathology*
  • Mitochondrial Swelling / drug effects
  • Mitochondrial Swelling / physiology
  • Neurons / drug effects*
  • Neurons / enzymology
  • Neurons / pathology*
  • Peptide Fragments / pharmacology*
  • Rats

Substances

  • Amyloid beta-Peptides
  • Peptide Fragments
  • amyloid beta-protein (35-25)